Select Medical (NYSE:SEM) Releases Quarterly Earnings Results, Misses Expectations By $0.11 EPS

Select Medical (NYSE:SEM) announced its quarterly earnings data on Thursday. The health services provider reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.29 by ($0.11), Zacks reports. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The firm had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.50 billion. Select Medical updated its FY 2025 guidance to 1.090-1.190 EPS.

Select Medical Stock Performance

SEM stock traded down $1.95 during trading on Friday, reaching $17.12. 733,188 shares of the stock were exchanged, compared to its average volume of 780,408. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The stock has a 50 day simple moving average of $19.13 and a 200-day simple moving average of $28.07. The company has a market capitalization of $2.22 billion, a P/E ratio of 7.98, a price-to-earnings-growth ratio of 0.64 and a beta of 1.45. Select Medical has a twelve month low of $16.20 and a twelve month high of $40.98.

Insider Buying and Selling at Select Medical

In other Select Medical news, VP Robert G. Breighner, Jr. sold 4,989 shares of the company’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total transaction of $99,530.55. Following the transaction, the vice president now owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. This represents a 14.12 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of the firm’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the sale, the director now directly owns 22,000 shares in the company, valued at $463,980. The trade was a 59.26 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 19.14% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on SEM shares. StockNews.com upgraded Select Medical from a “hold” rating to a “buy” rating in a report on Friday. Royal Bank of Canada increased their price objective on Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. UBS Group cut their target price on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a report on Friday, January 3rd. Finally, Benchmark lowered Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $39.50.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.